Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-02-14
2006-02-14
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S300100, C548S347100, C548S348100
Reexamination Certificate
active
06998414
ABSTRACT:
Compounds effective as IP receptor modulators, particularly IP receptor antagonists, that are of the formula I:wherein A, R1, R2, R3and R4are as defined in the specification; and individual isomers, racemic or non-racemic mixtures of isomers, and pharmaceutically acceptable salts or solvates thereof. Also disclosed are pharmaceutical compositions containing such compounds and methods for their use as therapeutic agents.
REFERENCES:
patent: 4396617 (1983-08-01), Dolman et al.
patent: 5741796 (1998-04-01), Hartman et al.
patent: 6184242 (2001-02-01), Bley et al.
patent: 6417186 (2002-07-01), Jahangir
patent: 0017484 (1980-10-01), None
patent: 0 902 018 (1998-03-01), None
patent: WO 00/72840 (2000-12-01), None
patent: WO 02/40453 (2002-05-01), None
LeClerc, Gerard et al., Agents alpha-adrenergiques alcoylants, European Journal of Medicine, 1983-18, No. 4, pp. 379-383.
Jahangir Alam
Keitz Paul Francis
Lopez-Tapia Francisco Javier
O'Yang Counde
Hall Robert C.
Lee Susannah E.
Roche Palo Alto LLC
Saeed Kamal A.
LandOfFree
Substituted arylamides as IP antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted arylamides as IP antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted arylamides as IP antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3653471